[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR101436516B1 - 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 - Google Patents

코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 Download PDF

Info

Publication number
KR101436516B1
KR101436516B1 KR1020070073396A KR20070073396A KR101436516B1 KR 101436516 B1 KR101436516 B1 KR 101436516B1 KR 1020070073396 A KR1020070073396 A KR 1020070073396A KR 20070073396 A KR20070073396 A KR 20070073396A KR 101436516 B1 KR101436516 B1 KR 101436516B1
Authority
KR
South Korea
Prior art keywords
weight
suspension
drug
pellet
amount
Prior art date
Application number
KR1020070073396A
Other languages
English (en)
Korean (ko)
Other versions
KR20090010352A (ko
Inventor
신광현
빈성아
김경국
배준호
김정주
Original Assignee
주식회사태평양제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사태평양제약 filed Critical 주식회사태평양제약
Priority to KR1020070073396A priority Critical patent/KR101436516B1/ko
Priority to PCT/KR2008/004298 priority patent/WO2009014372A2/en
Priority to CN2008800253313A priority patent/CN101754754B/zh
Publication of KR20090010352A publication Critical patent/KR20090010352A/ko
Application granted granted Critical
Publication of KR101436516B1 publication Critical patent/KR101436516B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
KR1020070073396A 2007-07-23 2007-07-23 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 KR101436516B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020070073396A KR101436516B1 (ko) 2007-07-23 2007-07-23 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
PCT/KR2008/004298 WO2009014372A2 (en) 2007-07-23 2008-07-23 Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof
CN2008800253313A CN101754754B (zh) 2007-07-23 2008-07-23 含有包覆的含药物的颗粒的可分散药片及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070073396A KR101436516B1 (ko) 2007-07-23 2007-07-23 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법

Publications (2)

Publication Number Publication Date
KR20090010352A KR20090010352A (ko) 2009-01-30
KR101436516B1 true KR101436516B1 (ko) 2014-09-02

Family

ID=40281977

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070073396A KR101436516B1 (ko) 2007-07-23 2007-07-23 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법

Country Status (3)

Country Link
KR (1) KR101436516B1 (zh)
CN (1) CN101754754B (zh)
WO (1) WO2009014372A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102475689B (zh) * 2010-11-30 2015-04-01 杭州赛利药物研究所有限公司 混悬分散片及其制备方法
CN103040776A (zh) * 2012-12-14 2013-04-17 四川美大康药业股份有限公司 阿奇霉素分散片颗粒包衣的制备方法
ITUA20163981A1 (it) * 2016-05-31 2017-12-01 Zambon Spa Composizioni farmaceutiche comprendenti safinamide
CN112076168A (zh) * 2020-09-24 2020-12-15 丽珠集团丽珠制药厂 一种罗红霉素分散片及其制备方法
CN115501196B (zh) * 2022-10-31 2023-04-11 江苏神龙药业有限公司 一种罗红霉素分散片的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087112A1 (en) * 2003-03-31 2004-10-14 Korea United Pharm, Inc. Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
CA2587022A1 (en) * 1998-05-18 1999-11-25 Takeda Pharmaceutical Company Limited Orally disintegrable tablets
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
CN1543971A (zh) * 2003-07-02 2004-11-10 北京博尔达生物技术开发有限公司 复方丹参口腔崩解片及制备方法
CN1274298C (zh) * 2003-11-06 2006-09-13 常州市第四制药厂有限公司 一种有效掩味的口腔崩解片及制备方法
CN100376258C (zh) * 2005-05-27 2008-03-26 北京科信必成医药科技发展有限公司 一种心力丸口腔崩解片及其制备方法
CN100448431C (zh) * 2005-10-17 2009-01-07 重庆医药工业研究院有限责任公司 一种用于治疗儿童感冒的氨酚麻美口腔崩解片及制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087112A1 (en) * 2003-03-31 2004-10-14 Korea United Pharm, Inc. Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin

Also Published As

Publication number Publication date
WO2009014372A3 (en) 2009-03-19
CN101754754A (zh) 2010-06-23
WO2009014372A2 (en) 2009-01-29
CN101754754B (zh) 2013-06-19
KR20090010352A (ko) 2009-01-30

Similar Documents

Publication Publication Date Title
CA2823166C (en) Orally disintegrating tablet
KR101032289B1 (ko) 미세과립
AU2009236271B2 (en) Compositions comprising weakly basic drugs and controlled-release dosage forms
KR101489401B1 (ko) 약 염기성 약물과 유기산을 포함하는 약물 전달 시스템
TW200944249A (en) Orally-disintegrating solid preparation
US8747895B2 (en) Orally disintegrating tablets of atomoxetine
KR101436516B1 (ko) 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
WO2011082426A1 (en) Controlled release compositions comprising meclizine or related piperazine derivatives
US9962342B1 (en) Pharmaceutical composition containing guaifenesin and application thereof
US20100151015A1 (en) Compositions Comprising Melperone and Controlled-Release Dosage Forms
AU2013204400B2 (en) Drug delivery systems comprising weakly basic drugs and organic acids
MX2008009613A (en) Drug delivery systems comprising weakly basic drugs and organic acids

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
LAPS Lapse due to unpaid annual fee